India, Aug. 27 -- Today's top gainers in the biotech and healthcare space include Propanc Biopharma, following strong preclinical pancreatic cancer data; VolitionRx, after positive validation of its Nu.Q NETs biomarker; Nutanix, on higher quarterly revenue and profit; Xtant Medical, following a BioHorizons partnership; Biomerica, after announcing a private placement and strategic review; and Celularity, on a potential $300 million MuseCell manufacturing deal.
Read on...
PPCB Surges 203% As PRP Shows Strong Tumor Inhibition In Pancreatic Cancer
Propanc Biopharma, Inc. (PPCB) shares surged 202.75% after the company reported preclinical and early translational data showing its lead candidate, PRP, achieved more than 90% mean tumor growth in...